Saxena Parag

Reviva Pharmaceuticals Holdings, Inc. · Director

Saxena Parag is listed in filings as Director at Reviva Pharmaceuticals Holdings, Inc.. This profile follows SEC Form 4 activity through Dec 19, 2025, including 2 public disclosures. Recent filings connect the profile to Reviva Pharmaceuticals Holdings, Inc. (RVPH). The current snapshot covers public activity from Dec 12, 2024 to Dec 19, 2025. Reported amounts are shown as $4.8K to $20.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.